Intra-Osseous Access in Difficult Vascular Access Cases (IODA)

March 11, 2025 updated by: Assistance Publique - Hôpitaux de Paris

Thousands of peripheral venous accesses are inserted every day all over the world. Some of them, such as those inserted in emergency and / or in critical patients, are absolutely vital. In the particular context of prehospital care, the rate of failure of the first attempt to insert a peripheral venous access has been evaluated at 25%. Success rates of successive attempts were about 75%. Nevertheless, the final success rate is close to 100%.

Failure or delay in obtaining venous access can be life-threatening. Thus, alternatives to peripheral venous access have been proposed including intraosseous route recently made easier by the development of an automated puncture device (EZ-IO®), but still rarely used, especially on conscious patient.

Currently, the place of intraosseous venous access in critical patients is not determined.

Study Overview

Study Type

Interventional

Enrollment (Actual)

3

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bobigny, France, 93000
        • Hôpital Avicenne

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Adult patient, in prehospital setting, without venous access and after failure of the first attempt to place a peripheral venous access by a senior operator (doctor or nurse) AND
  2. Patient with hemodynamic failure defined as:

    • systolic blood pressure (SBP) < 90 mm Hg (2 measures) or
    • cardiac arrest or
  3. Any situation requiring intubation

Exclusion Criteria:

  • 1- Age < 18 years

    2- Venous access already available

    3- Known contra-indications to intraosseous access (i.e. bilateral lesions):

  • Bone fracture
  • Skin infection
  • Osteoporosis
  • Osteomyelitis
  • Local burns
  • Recent failed intraosseous attempt
  • Prior surgery
  • Compartment syndrome
  • Every other local specific situations

    4- Pregnancy woman

    5- Patient with no national health or universal plan affiliation coverage

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: intraosseous venous access
Immediate placement of humeral intra-osseous venous access (after a first failed attempt of peripheral venous access)
Active Comparator: peripheral venous access
Limiting use of intraosseous access (intraosseous access possible after 3 attempts of peripheral venous access)
Looking for peripheral venous access, changing the site of puncture, the caliber of the catheter and/or the operator and/or assistance tools (ultrasound, infra-red guidance...) and/or using another route (oral, rectal, subcutaneous, intramuscular route and central venous access)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To demonstrate that the early recourse to the intraosseous route, from the first failure, makes it possible to obtain more quickly the correction of the failure of critical patient managed in prehospital setting.
Time Frame: • In patients with cardiac arrest: Return of spontaneous circulation (ROSC), an average of 1 hour

• In patients with cardiac arrest: Time required for a return of spontaneous circulation (ROSC).

Only the first ROSC will be considered.

• In patients with cardiac arrest: Return of spontaneous circulation (ROSC), an average of 1 hour
To demonstrate that the early recourse to the intraosseous route, from the first failure, makes it possible to obtain more quickly the correction of the failure of critical patient managed in prehospital setting.
Time Frame: • In patients with hemodynamic failure: Reach a systolic blood pressure correction, an average of 1 hour

• In patients with hemodynamic failure: delay to reach a systolic blood pressure correction, i.e. systolic blood pressure > 90 mm Hg.

Systolic blood pressure will be assessed every 5 minutes after the placement of the intravenous line. Two consecutive measures are required to reach the end-point.

In the cases where continuous invasive blood pressure monitoring will be available, systolic blood pressure > 90 mm Hg > 1 minute will be required.

• In patients with hemodynamic failure: Reach a systolic blood pressure correction, an average of 1 hour
To demonstrate that the early recourse to the intraosseous route, from the first failure, makes it possible to obtain more quickly the correction of the failure of critical patient managed in prehospital setting.
Time Frame: • In patients requiring endo-tracheal intubation: Achieve intubation, an average of 1 hour
• In patients requiring endo-tracheal intubation: time required to achieve intubation.
• In patients requiring endo-tracheal intubation: Achieve intubation, an average of 1 hour

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To characterize the conditions for implementation of the procedure, depending on the strategy used.
Time Frame: 1 minute
Failure to place the catheter defined by the absence of infusion or by withdrawal of the catheter within one minute after the opening of the infusion
1 minute
To characterize the conditions for implementation of the procedure, depending on the strategy used.
Time Frame: In patients with cardiac arrest: Return of spontaneous circulation (ROSC), an average of 1 hour
Number of punctures
In patients with cardiac arrest: Return of spontaneous circulation (ROSC), an average of 1 hour
To characterize the conditions for implementation of the procedure, depending on the strategy used.
Time Frame: In patients with hemodynamic failure: Reach a systolic blood pressure correction, an average of 1 hour
Number of punctures
In patients with hemodynamic failure: Reach a systolic blood pressure correction, an average of 1 hour
To characterize the conditions for implementation of the procedure, depending on the strategy used.
Time Frame: In patients requiring endo-tracheal intubation: Achieve intubation, an average of 1 hour
Number of sites treated
In patients requiring endo-tracheal intubation: Achieve intubation, an average of 1 hour
To characterize the conditions for implementation of the procedure, depending on the strategy used.
Time Frame: In patients with cardiac arrest: Return of spontaneous circulation (ROSC). In patients with hemodynamic failure: Reach a systolic blood pressure correction. In patients requiring endo-tracheal intubation: Achieve intubation
Use of alternative routes (central venous access, oral, rectal, subcutaneous, intramuscular - and intra-osseous in the control group)
In patients with cardiac arrest: Return of spontaneous circulation (ROSC). In patients with hemodynamic failure: Reach a systolic blood pressure correction. In patients requiring endo-tracheal intubation: Achieve intubation
To characterize the conditions for implementation of the procedure, depending on the strategy used.
Time Frame: In patients with cardiac arrest: Return of spontaneous circulation (ROSC), an average of 1 hour
Use of alternative routes (central venous access, oral, rectal, subcutaneous, intramuscular - and intra-osseous in the control group)
In patients with cardiac arrest: Return of spontaneous circulation (ROSC), an average of 1 hour
To characterize the conditions for implementation of the procedure, depending on the strategy used.
Time Frame: In patients with hemodynamic failure: Reach a systolic blood pressure correction, an average of 1 hour
Use of alternative routes (central venous access, oral, rectal, subcutaneous, intramuscular - and intra-osseous in the control group)
In patients with hemodynamic failure: Reach a systolic blood pressure correction, an average of 1 hour
To characterize the conditions for implementation of the procedure, depending on the strategy used.
Time Frame: In patients requiring endo-tracheal intubation: Achieve intubation, an average of 1 hour
Use of assistance tools (ultrasound, infra-red)
In patients requiring endo-tracheal intubation: Achieve intubation, an average of 1 hour
To characterize the conditions for implementation of the procedure, depending on the strategy used.
Time Frame: In patients with cardiac arrest: Return of spontaneous circulation (ROSC). In patients with hemodynamic failure: Reach a systolic blood pressure correction. In patients requiring endo-tracheal intubation: Achieve intubation
Delays in placing venous access
In patients with cardiac arrest: Return of spontaneous circulation (ROSC). In patients with hemodynamic failure: Reach a systolic blood pressure correction. In patients requiring endo-tracheal intubation: Achieve intubation
To characterize the conditions for implementation of the procedure, depending on the strategy used.
Time Frame: In patients with cardiac arrest: Return of spontaneous circulation (ROSC), an average of 1 hour
Delays in placing venous access
In patients with cardiac arrest: Return of spontaneous circulation (ROSC), an average of 1 hour
To characterize the conditions for implementation of the procedure, depending on the strategy used.
Time Frame: In patients with hemodynamic failure: Reach a systolic blood pressure correction, an average of 1 hour
Delays in placing venous access
In patients with hemodynamic failure: Reach a systolic blood pressure correction, an average of 1 hour
To characterize the conditions for implementation of the procedure, depending on the strategy used.
Time Frame: In patients with cardiac arrest: Return of spontaneous circulation (ROSC), an average of 1 hour
Delays for administration of drugs/solutes
In patients with cardiac arrest: Return of spontaneous circulation (ROSC), an average of 1 hour
To characterize the conditions for implementation of the procedure, depending on the strategy used.
Time Frame: In patients with hemodynamic failure: Reach a systolic blood pressure correction, an average of 1 hour
Delays for administration of drugs/solutes
In patients with hemodynamic failure: Reach a systolic blood pressure correction, an average of 1 hour
To characterize the conditions for implementation of the procedure, depending on the strategy used.
Time Frame: In patients requiring endo-tracheal intubation: Achieve intubation, an average of 1 hour
Delays for administration of drugs/solutes
In patients requiring endo-tracheal intubation: Achieve intubation, an average of 1 hour
To determine the length of stay in hospital
Time Frame: Days 28
Length of stay in hospital
Days 28
To evaluate morbidity depending on the strategy used.
Time Frame: In patients with cardiac arrest: Return of spontaneous circulation (ROSC), an average of 1 hour
Non-functional venous
In patients with cardiac arrest: Return of spontaneous circulation (ROSC), an average of 1 hour
To evaluate morbidity depending on the strategy used.
Time Frame: In patients with hemodynamic failure: Reach a systolic blood pressure correction, an average of 1 hour
Non-functional venous
In patients with hemodynamic failure: Reach a systolic blood pressure correction, an average of 1 hour
To evaluate morbidity depending on the strategy used.
Time Frame: IIn patients requiring endo-tracheal intubation: Achieve intubation, In patients with hemodynamic failure: Reach a systolic blood pressure correction, an average of 1 hour
Non-functional venous
IIn patients requiring endo-tracheal intubation: Achieve intubation, In patients with hemodynamic failure: Reach a systolic blood pressure correction, an average of 1 hour
To evaluate morbidity depending on the strategy used.
Time Frame: Days 28
Local complication (subcutaneous diffusion, hematoma, pain...)
Days 28
To evaluate morbidity depending on the strategy used.
Time Frame: Hours 72
Need to replace the venous access
Hours 72
To evaluate mortality depending on the strategy used.
Time Frame: Days 28
Death
Days 28
To evaluate the patient's feedback, depending on the strategy used.
Time Frame: Immediately after the insertion of the catheter (opening of the perfusion) and on arrival at the hospital, In patients with hemodynamic failure: Reach a systolic blood pressure correction, an average of 1 hour
Evaluation of procedural pain on an analog visual scale, EVA, simple verbal scale, EVS or numerical scale, EN (from 0 to 100, the higher is the worse) In the case of patient with cardiac arrest, only the operator satisfaction will be assessed.
Immediately after the insertion of the catheter (opening of the perfusion) and on arrival at the hospital, In patients with hemodynamic failure: Reach a systolic blood pressure correction, an average of 1 hour
To evaluate the team's feedback, depending on the strategy used.
Time Frame: Immediately after the insertion of the catheter (opening of the perfusion) and on arrival at the hospital, In patients with hemodynamic failure: Reach a systolic blood pressure correction, an average of 1 hour
Operator satisfaction assessed (EVA, EVS or EN) after the placement of the catheter and on arrival at the hospital (from 0 to 100, the higher is the worse).
Immediately after the insertion of the catheter (opening of the perfusion) and on arrival at the hospital, In patients with hemodynamic failure: Reach a systolic blood pressure correction, an average of 1 hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: LAPOSTOLLE Frédéric, PhD MD, APHP

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 2, 2023

Primary Completion (Actual)

April 24, 2024

Study Completion (Actual)

September 10, 2024

Study Registration Dates

First Submitted

April 6, 2022

First Submitted That Met QC Criteria

January 24, 2023

First Posted (Actual)

February 1, 2023

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 11, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • P170918J

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hemodynamic Instability

Clinical Trials on Intraosseous venous access

Subscribe